Mr. Chair, Amanda suffers from a serious disease called cystic fibrosis. Because of her condition she is also vulnerable to severe COVID-19. Although she's one of the lucky 95 very ill Canadians who will receive the medication Trikafta through a special access program, she is concerned about the other 4,000-plus Canadians with cystic fibrosis who can't get the medication because of the lack of government approval and the minister's failure to listen to patients.
Conservatives have been calling on the government to delay changes to the PMPRB guidelines, changes that would likely make it harder for patients to get the medicine they need, and the government finally listened, but will the minister acknowledge there are still real flaws with the proposed changes?